Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

被引：11
|
作者：
Gardini, A. C. [1 ]
Foschi, F. G. [2 ]
Conti, F. [3 ]
Petracci, E. [4 ]
Marisi, G. [5 ]
Buonfiglioli, F. [3 ]
Ravaioli, M. [3 ]
Mazzella, G. [6 ]
Muratori, P. [7 ,8 ]
Lenzi, M. [7 ,8 ]
Crespi, C. [9 ]
Bolondi, L. [6 ]
Badia, L. [10 ]
Verucchi, G. [3 ]
Vitale, G. [3 ]
Vukotic, R. [3 ]
Brillanti, S. [3 ]
Andreone, P. [3 ]
机构：
[1] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Dept Med Oncol, Meldola, Italy
[2] AUSL Romagna, DPT Internal Med, Faenza Hosp, Forli, Italy
[3] Univ Bologna, Res Ctr Study Hepatitis, Dept Med & Surg Sci DIMEC, Bologna, Italy
[4] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Unit Biostat & Clin Trials, Meldola, Italy
[5] IRST IRCCS, Biosci Lab, Meldola, Italy
[6] Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy
[7] Policlin St Orsola, Ctr Study & Treatment Autoimmune Dis Liver & Bili, Bologna, Italy
[8] Univ Bologna, Dept Med & Surg Sci DIMEC, Alma Mater Studiorum, Bologna, Italy
[9] St Orsola Marcello Malpighi Hosp, Dept Digest Dis, Bologna, Italy
[10] Univ Bologna, Infect Dis Unit, Dept Med & Surg Sci, Hosp S Orsola Malpighi, Bologna, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2018年 / 50卷 / 01期
关键词：
D O I：
10.1016/j.dld.2018.01.055
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
F-17
引用
收藏
页码：50 / 51
页数：2
相关论文
共 50 条
  • [21] Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals
    Kishta, Sara
    Tabll, Ashraf
    Kolaric, Tea Omanovic
    Smolic, Robert
    Smolic, Martina
    BIOMEDICINES, 2020, 8 (06) : 1 - 15
  • [22] Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals
    Calvaruso, V.
    Cabibbo, G.
    Cacciola, I.
    Petta, S.
    Madonia, S.
    Bellia, A.
    Stefano, M. D.
    Giannitrapani, L.
    Tine, F.
    Magro, A.
    Davi, A.
    Larocca, L.
    Ardiri, A.
    Digiacomo, A.
    Gussio, M.
    Guarneri, L.
    Scalisi, I.
    Mazzola, G.
    Cartabellotta, F.
    Savalli, F.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Camma, C.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S23 - S24
  • [23] Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
    Renzulli, Matteo
    Buonfiglioli, Federica
    Conti, Fabio
    Brocchi, Stefano
    Serio, Ilaria
    Foschi, Francesco Giuseppe
    Caraceni, Paolo
    Mazzella, Giuseppe
    Verucchi, Gabriella
    Golfieri, Rita
    Andreone, Pietro
    Brillanti, Stefano
    EUROPEAN RADIOLOGY, 2018, 28 (02) : 506 - 513
  • [24] Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
    Matteo Renzulli
    Federica Buonfiglioli
    Fabio Conti
    Stefano Brocchi
    Ilaria Serio
    Francesco Giuseppe Foschi
    Paolo Caraceni
    Giuseppe Mazzella
    Gabriella Verucchi
    Rita Golfieri
    Pietro Andreone
    Stefano Brillanti
    European Radiology, 2018, 28 : 506 - 513
  • [25] Early occurence of hepatocellular carcinoma in patients with and without cirrhosis after HCV treatment with direct-acting antivirals
    Finkelmeier, F.
    Dultz, G.
    Kronenberger, B.
    Peiffer, K-H.
    Krauss, F.
    Zeuzem, S.
    Sarrazin, C.
    Vermehren, J.
    Waidmann, O.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 61 - 61
  • [26] Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
    Amr Shaaban Hanafy
    Mohamed A. Bassiony
    Mohammad Abd Alkhalik Basha
    Hepatology International, 2019, 13 : 165 - 172
  • [27] Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
    Kinoshita, Mizuki Nishibatake
    Minami, Tatsuya
    Tateishi, Ryosuke
    Wake, Taijiro
    Nakagomi, Ryo
    Fujiwara, Naoto
    Sato, Masaya
    Uchino, Koji
    Enooku, Kenichiro
    Nakagawa, Hayato
    Asaoka, Yoshinari
    Shiina, Shuichiro
    Koike, Kazuhiko
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : 78 - 86
  • [28] Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals
    Gardini, Andrea Casadei
    Conti, Fabio
    Foschi, Francesco Giuseppe
    Brillanti, Stefano
    Andreone, Pietro
    GASTROENTEROLOGY, 2018, 154 (08) : 2281 - 2282
  • [29] TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals
    Degasperi, Elisabetta
    Galmozzi, Enrico
    Facchetti, Floriana
    Farina, Elisa
    D'Ambrosio, Roberta
    Soffredini, Roberta
    Iavarone, Massimo
    Lampertico, Pietro
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (10) : 1233 - 1236
  • [30] Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals
    Nicoletti, Alberto
    Ainora, Maria Elena
    Cintoni, Marco
    Garcovich, Matteo
    Funaro, Barbara
    Pecere, Silvia
    De Siena, Martina
    Santopaolo, Francesco
    Ponziani, Francesca Romana
    Riccardi, Laura
    Grieco, Antonio
    Pompili, Maurizio
    Gasbarrini, Antonio
    Zocco, Maria Assunta
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (11) : 1472 - 1479
12345